Actinium Pharmaceuticals Inc Share Price

NYSE: ATNM

Small Cap

$1.62

(+-0.31%)

as on September 16, 2025 at 1:29 am IST

$₹

Actinium Pharmaceuticals Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$1.6
Day's Price Range
$1.63
$1.62
1.23%
Downside
0.62%
Upside
52 Week's Low
52 Week's High
$1.03
52-Week Price Range
$2.41
$1.62
36.47%
Downside
48.77%
Upside

Actinium Pharmaceuticals Inc share price movements today

Previous Close: $1.63
Open: $1.63
Volume: 201.5K
Day's Low - High: $1.6 - $1.63
52 Week Low - High: $1.03 - $2.41

Actinium Pharmaceuticals Inc Historical Returns

1 Month Return: -3.55 %
3 Month Return: + 9.4 %
1 Year Return: -12.37 %
3 Year Return: -79.88 %
5 Year Return: -82.68 %

Actinium Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Actinium Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$50.8M

EPS (TTM)

-1.335

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-44.0M

Revenue (TTM)

81.0K

Profit Margin

0.00%

Return On Equity TTM

5576100.00%

Actinium Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Actinium Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Actinium Pharmaceuticals Inc	BUY	$50.8M	-82.68%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Actinium Pharmaceuticals Inc Stock including INR - Dollar returns

The Actinium Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Actinium Pharmaceuticals Inc investment value today

Current value as on today

₹92,082

Returns

₹7,918

(-7.92%)

Returns from Actinium Pharmaceuticals Inc Stock

₹12,903 (-12.9%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Actinium Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Actinium Pharmaceuticals Inc. Average target price of $5

Actinium Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Actinium Pharmaceuticals Inc.

What analysts predicted

67.6%UPSIDE

Target Price

Current Price

$1.62

Analyzed by

12 Analysts

Target

$5.00

Actinium Pharmaceuticals Inc target price $5, a slight upside of 67.6% compared to current price of $1.62. According to 12 analysts rating.

Actinium Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Actinium Pharmaceuticals Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-50% versus previous 30 day period

Actinium Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-11	-15	-14	-10	-9	-12	-12	-7	-16	-7
EBITDA	-11	-15	-14	-10	-9	-12	-12	-7	-16	-7
Interest Expense	0	0	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-15	-13	-9	-8	-11	-11	-6	-15	-6
Income Tax Expense	0	0	0	0	0	-	-11	-	-	-
Net Income	-11	-15	-13	-9	-8	-11	-11	-6	-15	-6
Net Profit Margin	0.00%	0.00%	0.00%	-11511.11%	0.00%	0.00%	0.00%	-821.23%	0.00%	0.00%

Actinium Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	0	1	1	0	-
Gross Profit	0	0	0	0	0	0	1	1	0	0
Operating Income	-24	-26	-26	-23	-22	-22	-24	-34	-51	-42
EBITDA	-24	-26	-26	-23	-21	-21	-24	-33	-51	-37
Interest Expense	0	0	0	0	-	-	0	1	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-21	-24	-26	-23	-21	-22	-24	-33	-48	-38
Income Tax Expense	0	0	0	0	0	0	0	-1	0	-
Net Income	-21	-24	-26	-23	-21	-22	-24	-33	-48	-38
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-3571.54%	-2165.56%	-3205.53%	-60269.14%	0.00%

Actinium Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-15	-13	-9	-8	-11	-11	-6	-15	-6
Operating Cash Flow	-13	-11	-7	-7	-7	-11	-5	-7	-5
Investing Cash Flow	0	0	-	0	-	-	-	-	-
Financing Cash Flow	10	2	1	14	9	4	0	0	0
Change in Cash	-3	-8	-6	7	1	-7	-5	-7	-5

Actinium Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-24	-26	-23	-21	-22	-24	-33	-48	-38
Operating Cash Flow	-20	-21	-20	-21	-21	-20	8	-47	-33
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	15	18	16	17	76	35	23	14	29
Change in Cash	-5	-3	-3	-4	54	14	31	-32	-3

Insights on Actinium Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -15.93M → -6.87M (in $), with an average increase of 131.7% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 81.0K → 810.0K (in $), with an average increase of 90.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 79.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 196.2%
NEGATIVE IMPACT
Price Dip
In the last 3 years, ATNM stock has moved down by -79.7%

About Actinium Pharmaceuticals Inc

actinium pharmaceuticals, inc. (www.actiniumpharma.com) (nyse mkt: atnm) is a new york-based biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. actinium's targeted radiotherapy is based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting actinium-225 and bismuth-213 and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. the company’s lead radiopharmaceutical iomab™-b will be used in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. the company is preparing a single, pivotal, multicenter phase 3 clinical study of iomab™-b in refractory and relapsed acute myeloid leukemia (aml) patients over the age of 55 with a primary endpoint of durable complete remission. the company’s second program, actimab-a, is continuing its clinical development in a phase 1/2 trial for newly diagnosed aml patients o

Organisation	Actinium Pharmaceuticals Inc
Headquarters	100 Park Avenue, New York, NY, United States, 10017
Industry	Health Technology
CEO	Mr. Sandesh C. Seth M.B.A., M.S.
E-voting on shares	Click here to vote

Key Management of Actinium Pharmaceuticals Inc

Name	Title
Dr. Avinash Desai M.D.	Chief Medical Officer
Ms. Lynn M. Bodarky M.B.A.	Chief Business Officer
Mr. Sandesh C. Seth M.B.A., M.S.	Chairman & CEO
Dr. Paul Diamond Esq., Ph.D.	Vice President of Patent & Legal Counsel
Ms. Jenny Hsieh	Chief Strategy Officer
Ms. Caroline Yarbrough	Chief Commercial Officer
Mr. J. C. Simeon	Executive Director of Quality Assurance
Dr. Madhuri Vusirikala M.D.	Vice President of Clinical Development BMT & Cellular Therapy
Mr. Steven O'Loughlin BS	CFO & Corporate Secretary

FAQs

What is Actinium Pharmaceuticals Inc share price today?

Actinium Pharmaceuticals Inc share price today is $1.62 as on September 16, 2025 at 1:29 am IST at the close of the market. Actinium Pharmaceuticals Inc share today touched a day high of $1.63 and a low of $1.6.

What is the 52 week high and 52 week low for Actinium Pharmaceuticals Inc share?

Actinium Pharmaceuticals Inc share touched a 52 week high of $2.41 on March 26, 2025 and a 52 week low of $1.03 on March 4, 2025. Actinium Pharmaceuticals Inc stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $1.62,which is 32.78% down from its 52 week high and 57.40% up from its 52 week low.

What is Actinium Pharmaceuticals Inc's market capitalisation today?

Actinium Pharmaceuticals Inc market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Actinium Pharmaceuticals Inc Stock (ATNM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Actinium Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Actinium Pharmaceuticals Inc Shares that will get you 0.9259 shares as per Actinium Pharmaceuticals Inc share price of $1.62 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Actinium Pharmaceuticals Inc Stock (ATNM) from India?

Indian investors can start investing in Actinium Pharmaceuticals Inc (ATNM) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 12:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Actinium Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 12:40 pm IST). Based on Actinium Pharmaceuticals Inc share’s latest price of $1.62 as on September 16, 2025 at 1:29 am IST, you will get 6.1728 shares of Actinium Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Actinium Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Actinium Pharmaceuticals Inc stock has given -82.68% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?